Scale Asia Ventures - Venture capital firm
Scale Asia Ventures
Subtle Medical Named to the 2022 CB Insights' Digital Health 150 List
Companies valued at $100M+
With other international offices
Decentralized infrastructure, Cloud Native, Modern Data Stack, DevOps Tech, Open Core and Product-Led Growth, AI in CyberSecurity is the new normal AI+software will transform essential industries, from Life Sciences, Robotics, Biology to other Vertical Industries Co-Founder & CEO of Nylas Scale Asia Ventures and Wally’s robust operator network have been instrumental to Nylas’ growth Their support, technical expertise, and understanding of our product market fit have helped us to build and nurture connections with key partners, customers, and more
Wally has a great background as both investor and operator, and the US and Asian networks He also has been a strong believer in our vision to build a DNA App Store He made a quick investment decision for our recent round which is very important for founders
Co-founder and CEO of Metadata We’re excited to welcome Scale Asia Ventures(SAV) to our cap table Their support goes beyond capital as they brought in corporate and investor networks to help our business thrive and cross pollinate with their other portfolio companies
Founder and CEO, Kolena; Author of the book "Deep Learning for Vision Systems" Scale Asia Ventures showed insightful guidance based on their investment expertise in infrastructure software and ML/AI space, as well as their business development experience in the enterprise tech space Their extensive network of global corporate partners helped us a lot since the beginning of our journey together
CEO and Co-Founder at Molecula, Innovators of Austin We feel very lucky to work with Scale Asia Ventures and value their deep expertise up and down the modern data stack, their GTM perspective, and most importantly their global network of customers, investors, and talent
Korea’s major healthcare provider networks, Japan’s representative telecom company and software system integrators, Hong Kong-listed pharma & medical device companies, prominent financial institutions, conglomerates, tech titans as well as family offices across Asia
